 | • レポートコード：MRC2Q12-17018 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、生物学的硬膜代替物のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 生物学的硬膜代替物のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生物学的硬膜代替物の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生物学的硬膜代替物のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの生物学的硬膜代替物の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の生物学的硬膜代替物の売上および2028年までの予測に焦点を当てています。 生物学的硬膜代替物のグローバル主要企業には、B. Braun、Integra LifeSciences、Stryker、Baxter、Linacol Medical、Biosis Healing、COOK Medical、Vostra、TianXinFu Medical、Bioimplonなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 生物学的硬膜代替物市場は、タイプとアプリケーションによって区分されます。世界の生物学的硬膜代替物市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 ブタ小腸、ウシ踵骨、その他 【アプリケーション別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 生物学的硬膜代替物製品概要 - タイプ別市場（ブタ小腸、ウシ踵骨、その他） - アプリケーション別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の生物学的硬膜代替物販売量予測2017-2028 - 世界の生物学的硬膜代替物売上予測2017-2028 - 生物学的硬膜代替物の地域別販売量 - 生物学的硬膜代替物の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別生物学的硬膜代替物販売量 - 主要メーカー別生物学的硬膜代替物売上 - 主要メーカー別生物学的硬膜代替物価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（ブタ小腸、ウシ踵骨、その他） - 生物学的硬膜代替物のタイプ別販売量 - 生物学的硬膜代替物のタイプ別売上 - 生物学的硬膜代替物のタイプ別価格 ・アプリケーション別市場規模（病院、診療所、その他） - 生物学的硬膜代替物のアプリケーション別販売量 - 生物学的硬膜代替物のアプリケーション別売上 - 生物学的硬膜代替物のアプリケーション別価格 ・北米市場 - 北米の生物学的硬膜代替物市場規模（タイプ別、アプリケーション別） - 主要国別の生物学的硬膜代替物市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの生物学的硬膜代替物市場規模（タイプ別、アプリケーション別） - 主要国別の生物学的硬膜代替物市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の生物学的硬膜代替物市場規模（タイプ別、アプリケーション別） - 主要国別の生物学的硬膜代替物市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の生物学的硬膜代替物市場規模（タイプ別、アプリケーション別） - 主要国別の生物学的硬膜代替物市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの生物学的硬膜代替物市場規模（タイプ別、アプリケーション別） - 主要国別の生物学的硬膜代替物市場規模（トルコ、サウジアラビア） ・企業情報 B. Braun、Integra LifeSciences、Stryker、Baxter、Linacol Medical、Biosis Healing、COOK Medical、Vostra、TianXinFu Medical、Bioimplon ・産業チェーン及び販売チャネル分析 - 生物学的硬膜代替物の産業チェーン分析 - 生物学的硬膜代替物の原材料 - 生物学的硬膜代替物の生産プロセス - 生物学的硬膜代替物の販売及びマーケティング - 生物学的硬膜代替物の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 生物学的硬膜代替物の産業動向 - 生物学的硬膜代替物のマーケットドライバー - 生物学的硬膜代替物の課題 - 生物学的硬膜代替物の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Biological Dura Substitute is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Biological Dura Substitute is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Biological Dura Substitute is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Biological Dura Substitute include B. Braun, Integra LifeSciences, Stryker, Baxter, Linacol Medical, Biosis Healing, COOK Medical, Vostra and TianXinFu Medical, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Biological Dura Substitute manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Biological Dura Substitute market. Further, it explains the major drivers and regional dynamics of the global Biological Dura Substitute market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
B. Braun
Integra LifeSciences
Stryker
Baxter
Linacol Medical
Biosis Healing
COOK Medical
Vostra
TianXinFu Medical
Bioimplon
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Biological Dura Substitute Segment by Type
Porcine Small Intestinal
Bovine Calcaneal
Others
Biological Dura Substitute Segment by Application
Hospital
Clinic
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Biological Dura Substitute market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Biological Dura Substitute, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Biological Dura Substitute, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Biological Dura Substitute, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biological Dura Substitute sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Biological Dura Substitute market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Biological Dura Substitute sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including B. Braun, Integra LifeSciences, Stryker, Baxter, Linacol Medical, Biosis Healing, COOK Medical, Vostra and TianXinFu Medical, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Biological Dura Substitute in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Biological Dura Substitute manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biological Dura Substitute sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Biological Dura Substitute Product Introduction
1.2 Market by Type
1.2.1 Global Biological Dura Substitute Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Porcine Small Intestinal
1.2.3 Bovine Calcaneal
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biological Dura Substitute Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biological Dura Substitute Sales Estimates and Forecasts 2017-2028
2.2 Global Biological Dura Substitute Revenue Estimates and Forecasts 2017-2028
2.3 Global Biological Dura Substitute Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Biological Dura Substitute Sales by Region
2.4.1 Global Biological Dura Substitute Sales by Region (2017-2022)
2.4.2 Global Sales Biological Dura Substitute by Region (2023-2028)
2.5 Global Biological Dura Substitute Revenue by Region
2.5.1 Global Biological Dura Substitute Revenue by Region (2017-2022)
2.5.2 Global Biological Dura Substitute Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Biological Dura Substitute Sales by Manufacturers
3.1.1 Global Top Biological Dura Substitute Manufacturers by Sales (2017-2022)
3.1.2 Global Biological Dura Substitute Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biological Dura Substitute in 2021
3.2 Global Biological Dura Substitute Revenue by Manufacturers
3.2.1 Global Biological Dura Substitute Revenue by Manufacturers (2017-2022)
3.2.2 Global Biological Dura Substitute Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Biological Dura Substitute Revenue in 2021
3.3 Global Biological Dura Substitute Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Biological Dura Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Biological Dura Substitute Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biological Dura Substitute Sales by Type
4.1.1 Global Biological Dura Substitute Historical Sales by Type (2017-2022)
4.1.2 Global Biological Dura Substitute Forecasted Sales by Type (2023-2028)
4.1.3 Global Biological Dura Substitute Sales Market Share by Type (2017-2028)
4.2 Global Biological Dura Substitute Revenue by Type
4.2.1 Global Biological Dura Substitute Historical Revenue by Type (2017-2022)
4.2.2 Global Biological Dura Substitute Forecasted Revenue by Type (2023-2028)
4.2.3 Global Biological Dura Substitute Revenue Market Share by Type (2017-2028)
4.3 Global Biological Dura Substitute Price by Type
4.3.1 Global Biological Dura Substitute Price by Type (2017-2022)
4.3.2 Global Biological Dura Substitute Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Biological Dura Substitute Sales by Application
5.1.1 Global Biological Dura Substitute Historical Sales by Application (2017-2022)
5.1.2 Global Biological Dura Substitute Forecasted Sales by Application (2023-2028)
5.1.3 Global Biological Dura Substitute Sales Market Share by Application (2017-2028)
5.2 Global Biological Dura Substitute Revenue by Application
5.2.1 Global Biological Dura Substitute Historical Revenue by Application (2017-2022)
5.2.2 Global Biological Dura Substitute Forecasted Revenue by Application (2023-2028)
5.2.3 Global Biological Dura Substitute Revenue Market Share by Application (2017-2028)
5.3 Global Biological Dura Substitute Price by Application
5.3.1 Global Biological Dura Substitute Price by Application (2017-2022)
5.3.2 Global Biological Dura Substitute Price Forecast by Application (2023-2028)
6 North America
6.1 North America Biological Dura Substitute Market Size by Type
6.1.1 North America Biological Dura Substitute Sales by Type (2017-2028)
6.1.2 North America Biological Dura Substitute Revenue by Type (2017-2028)
6.2 North America Biological Dura Substitute Market Size by Application
6.2.1 North America Biological Dura Substitute Sales by Application (2017-2028)
6.2.2 North America Biological Dura Substitute Revenue by Application (2017-2028)
6.3 North America Biological Dura Substitute Market Size by Country
6.3.1 North America Biological Dura Substitute Sales by Country (2017-2028)
6.3.2 North America Biological Dura Substitute Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Biological Dura Substitute Market Size by Type
7.1.1 Europe Biological Dura Substitute Sales by Type (2017-2028)
7.1.2 Europe Biological Dura Substitute Revenue by Type (2017-2028)
7.2 Europe Biological Dura Substitute Market Size by Application
7.2.1 Europe Biological Dura Substitute Sales by Application (2017-2028)
7.2.2 Europe Biological Dura Substitute Revenue by Application (2017-2028)
7.3 Europe Biological Dura Substitute Market Size by Country
7.3.1 Europe Biological Dura Substitute Sales by Country (2017-2028)
7.3.2 Europe Biological Dura Substitute Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Biological Dura Substitute Market Size by Type
8.1.1 Asia Pacific Biological Dura Substitute Sales by Type (2017-2028)
8.1.2 Asia Pacific Biological Dura Substitute Revenue by Type (2017-2028)
8.2 Asia Pacific Biological Dura Substitute Market Size by Application
8.2.1 Asia Pacific Biological Dura Substitute Sales by Application (2017-2028)
8.2.2 Asia Pacific Biological Dura Substitute Revenue by Application (2017-2028)
8.3 Asia Pacific Biological Dura Substitute Market Size by Region
8.3.1 Asia Pacific Biological Dura Substitute Sales by Region (2017-2028)
8.3.2 Asia Pacific Biological Dura Substitute Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Biological Dura Substitute Market Size by Type
9.1.1 Latin America Biological Dura Substitute Sales by Type (2017-2028)
9.1.2 Latin America Biological Dura Substitute Revenue by Type (2017-2028)
9.2 Latin America Biological Dura Substitute Market Size by Application
9.2.1 Latin America Biological Dura Substitute Sales by Application (2017-2028)
9.2.2 Latin America Biological Dura Substitute Revenue by Application (2017-2028)
9.3 Latin America Biological Dura Substitute Market Size by Country
9.3.1 Latin America Biological Dura Substitute Sales by Country (2017-2028)
9.3.2 Latin America Biological Dura Substitute Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Biological Dura Substitute Market Size by Type
10.1.1 Middle East and Africa Biological Dura Substitute Sales by Type (2017-2028)
10.1.2 Middle East and Africa Biological Dura Substitute Revenue by Type (2017-2028)
10.2 Middle East and Africa Biological Dura Substitute Market Size by Application
10.2.1 Middle East and Africa Biological Dura Substitute Sales by Application (2017-2028)
10.2.2 Middle East and Africa Biological Dura Substitute Revenue by Application (2017-2028)
10.3 Middle East and Africa Biological Dura Substitute Market Size by Country
10.3.1 Middle East and Africa Biological Dura Substitute Sales by Country (2017-2028)
10.3.2 Middle East and Africa Biological Dura Substitute Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 B. Braun
11.1.1 B. Braun Corporation Information
11.1.2 B. Braun Overview
11.1.3 B. Braun Biological Dura Substitute Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 B. Braun Biological Dura Substitute Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 B. Braun Recent Developments
11.2 Integra LifeSciences
11.2.1 Integra LifeSciences Corporation Information
11.2.2 Integra LifeSciences Overview
11.2.3 Integra LifeSciences Biological Dura Substitute Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Integra LifeSciences Biological Dura Substitute Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Integra LifeSciences Recent Developments
11.3 Stryker
11.3.1 Stryker Corporation Information
11.3.2 Stryker Overview
11.3.3 Stryker Biological Dura Substitute Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Stryker Biological Dura Substitute Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Stryker Recent Developments
11.4 Baxter
11.4.1 Baxter Corporation Information
11.4.2 Baxter Overview
11.4.3 Baxter Biological Dura Substitute Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Baxter Biological Dura Substitute Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Baxter Recent Developments
11.5 Linacol Medical
11.5.1 Linacol Medical Corporation Information
11.5.2 Linacol Medical Overview
11.5.3 Linacol Medical Biological Dura Substitute Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Linacol Medical Biological Dura Substitute Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Linacol Medical Recent Developments
11.6 Biosis Healing
11.6.1 Biosis Healing Corporation Information
11.6.2 Biosis Healing Overview
11.6.3 Biosis Healing Biological Dura Substitute Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Biosis Healing Biological Dura Substitute Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Biosis Healing Recent Developments
11.7 COOK Medical
11.7.1 COOK Medical Corporation Information
11.7.2 COOK Medical Overview
11.7.3 COOK Medical Biological Dura Substitute Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 COOK Medical Biological Dura Substitute Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 COOK Medical Recent Developments
11.8 Vostra
11.8.1 Vostra Corporation Information
11.8.2 Vostra Overview
11.8.3 Vostra Biological Dura Substitute Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Vostra Biological Dura Substitute Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Vostra Recent Developments
11.9 TianXinFu Medical
11.9.1 TianXinFu Medical Corporation Information
11.9.2 TianXinFu Medical Overview
11.9.3 TianXinFu Medical Biological Dura Substitute Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 TianXinFu Medical Biological Dura Substitute Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 TianXinFu Medical Recent Developments
11.10 Bioimplon
11.10.1 Bioimplon Corporation Information
11.10.2 Bioimplon Overview
11.10.3 Bioimplon Biological Dura Substitute Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Bioimplon Biological Dura Substitute Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bioimplon Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biological Dura Substitute Industry Chain Analysis
12.2 Biological Dura Substitute Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biological Dura Substitute Production Mode & Process
12.4 Biological Dura Substitute Sales and Marketing
12.4.1 Biological Dura Substitute Sales Channels
12.4.2 Biological Dura Substitute Distributors
12.5 Biological Dura Substitute Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Biological Dura Substitute Industry Trends
13.2 Biological Dura Substitute Market Drivers
13.3 Biological Dura Substitute Market Challenges
13.4 Biological Dura Substitute Market Restraints
14 Key Findings in The Global Biological Dura Substitute Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer